Last updated on July 2019

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hypercholesterolemia | FAMILIAL HYPERCHOLESTEROLEMIA
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients for whom evolocumab is prescribed at participating medical institutions in accordance with the approved Japan prescribing information (i.e., those with Familial Hypercholesterolemia (Heterozygous or Homozygous and Hypercholesterolemia who have high risk factors for cardiovascular event and do not respond sufficiently to HMGCoA reductase inhibitor (statin) for hypercholesterolemia).

Exclusion Criteria:

  • No exclusion criteria are applied.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.